Suppr超能文献

多结节性桥本甲状腺炎中的抗甲状腺过氧化物酶抗体提示一种变异病因。

Antithyroid Peroxidase Antibodies in Multinodular Hashimoto's Thyroiditis Indicate a Variant Etiology.

作者信息

Mehanathan Pabithadevi B, Erusan R Raskin, Shantaraman K, Kannan S M

机构信息

General Surgery, Tirunelveli Medical College, Tirunelveli, India.

Multi Disciplinary Research Unit, Tirunelveli Medical College, Tirunelveli, India.

出版信息

J Thyroid Res. 2019 Jul 21;2019:4892329. doi: 10.1155/2019/4892329. eCollection 2019.

Abstract

INTRODUCTION

Hashimoto's thyroiditis (HT) is a common autoimmune thyroid disorder, which predominantly presents as a diffuse goiter, with few studies which report HT presenting as multinodular goiter, with variable frequencies ranging from 59% to 78.6% especially from south Indian populations. This variant clinical presentation may have diagnostic challenges which require further analysis. Anti-TPO antibodies are more common (90-95%) in Hashimoto's thyroiditis than anti-TG antibodies in Hashimoto's thyroiditis. This study analyzes the clinical features and the correlation of anti-TPO levels with diffuse and multinodular forms of HT.

MATERIAL AND METHODS

This study was conducted in the Department of General Surgery in a tertiary care hospital in south Tamil Nadu. Patients presenting with clinical features of a thyroid disorder were interviewed and given a detailed clinical, radiological examination and guided FNAC. Those patients diagnosed by FNAC as HT were registered and a sample of 3cc of blood was drawn for T3, T4, TSH, and anti-TPO analysis. All the data were tabulated.

RESULTS AND DISCUSSION

Of the 212 patients who presented with goiters, 96 were diagnosed by FNAC as having a cytological picture suggestive of Hashimoto's thyroiditis. Of these 96 patients with HT, 46 (47.9%) were multinodular (HT-MNG), 14 (14.58%) were solitary nodules (HT-SNT), and the remaining 36 (37.5%) were diffuse goiters (HT-D). Of the 46 patients who are HT-MNG, 36.9% had elevated anti-TPO-Ab (more than 35.0U/l) and 63.1% had normal/lower values (less than 35.0U/l). But of 36 patients with HT-D, 77.7% had elevated anti-TPO-Ab levels (>35U/l). Chi square statistics was 15.8346 and the p value is 0.0005 (<.05). Eight cases of HT-D and 3 cases of HT-MNG had hyperthyroidism and 3 cases of HT-D had hypothyroidism and all other cases were in euthyroid state.

CONCLUSION

Patients presenting as multinodular Hashimoto's thyroiditis have low prevalence of elevated anti-TPO-Ab than diffuse HT which suggests that multinodular form of Hashimoto's thyroiditis is a unique clinical entity with etiopathogenesis that is at variance with the diffuse form.

摘要

引言

桥本甲状腺炎(HT)是一种常见的自身免疫性甲状腺疾病,主要表现为弥漫性甲状腺肿,仅有少数研究报道HT表现为多结节性甲状腺肿,其发生率在59%至78.6%之间变化,特别是在印度南部人群中。这种不同的临床表现可能存在诊断挑战,需要进一步分析。在桥本甲状腺炎中,抗甲状腺过氧化物酶(Anti-TPO)抗体比抗甲状腺球蛋白(Anti-TG)抗体更常见(90 - 95%)。本研究分析了HT弥漫性和多结节性形式的临床特征以及抗TPO水平的相关性。

材料与方法

本研究在泰米尔纳德邦南部一家三级护理医院的普通外科进行。对出现甲状腺疾病临床特征的患者进行访谈,并给予详细的临床、放射学检查及引导下细针穿刺抽吸活检(FNAC)。那些经FNAC诊断为HT的患者进行登记,并抽取3cc血液样本进行T3、T4、促甲状腺激素(TSH)和抗TPO分析。所有数据制成表格。

结果与讨论

在212例出现甲状腺肿的患者中,96例经FNAC诊断为具有提示桥本甲状腺炎的细胞学表现。在这96例HT患者中,46例(47.9%)为多结节性(HT - MNG),14例(14.58%)为孤立结节(HT - SNT),其余36例(37.5%)为弥漫性甲状腺肿(HT - D)。在46例HT - MNG患者中,36.9%的抗TPO - Ab升高(超过35.0U/l),63.1%的值正常/较低(低于35.0U/l)。但在36例HT - D患者中,77.7%的抗TPO - Ab水平升高(>35U/l)。卡方统计值为15.8346,p值为0.0005(<.05)。8例HT - D和3例HT - MNG患者有甲状腺功能亢进,3例HT - D患者有甲状腺功能减退症,所有其他病例处于甲状腺功能正常状态。

结论

表现为多结节性桥本甲状腺炎的患者抗TPO - Ab升高的患病率低于弥漫性HT,这表明多结节性桥本甲状腺炎是一种独特的临床实体,其发病机制与弥漫性形式不同。

相似文献

7
Cytomorphological Spectrum of Thyroiditis: A Review of 110 Cases.甲状腺炎的细胞形态学谱:110例病例回顾
J Thyroid Res. 2018 Mar 1;2018:5246516. doi: 10.1155/2018/5246516. eCollection 2018.

引用本文的文献

本文引用的文献

6
The clinical use of thyroid function tests.甲状腺功能检查的临床应用。
Arq Bras Endocrinol Metabol. 2013 Apr;57(3):193-204. doi: 10.1590/s0004-27302013000300005.
8
Hashimoto's Thyroiditis: From Genes to the Disease.桥本甲状腺炎:从基因到疾病。
Curr Genomics. 2011 Dec;12(8):576-88. doi: 10.2174/138920211798120763.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验